In fact, we speculate that Btg2 may be highly expressed and play a role in promoting disease in diabetic nephropathy, membranous nephropathy, and minimal change disease manifested by podocyte injury, which needs to be further confirmed. Here, BTG2 is linked to lipoid nephrosis.